Natalizumab Ups JCV Seroconversion, Antibody Index in MSNatalizumab Ups JCV Seroconversion, Antibody Index in MS

New data shed some light on the mechanism behind the PML risk with natalizumab and emphasize the need for regular JC virus testing, researchers say. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news